Table 3.
Study | Country | Comparison and no. of the included patients | FICB strategy | Outcome parameters | Primary conclusions |
---|---|---|---|---|---|
Preoperative use | |||||
Foss et al. 2007 [24] | Denmark | FICB = 24 vs IM morphine = 24 | 40 mL 1.0% mepivacaine | VRS (rest/movement), total morphine consumption | FICB provided better pain relief at all times and at all measurements compared to IM morphine |
McRae et al.2015 [25] | Australia | FICB = 11 vs standard care (IV morphine) = 13 | 15–20 mL 2% lidocaine, weight-dependent | NRS, adverse events | FICB group had a greater reduction in pain than those who received standard care |
Wennberg et al. 2019 [26] | Sweden | FICB = 66 vs placebo (saline) = 61 (adjunctive therapy) | 30 mL 0.2% ropivacaine | VAS | Low-dose FICB improved pain management as a pain-relieving adjuvant to other analgesics |
Pasquier et al. 2019 [27] | Switzerland | FICB = 15 vs placebo (saline) = 15 (adjunctive therapy) | 30 mL 0.5% bupivacaine | NRS (rest/movement), total morphine consumption | Anatomic landmark-based FICB did not help reduce pain after prehospital morphine |
Godoy Monzón et al. 2010 [28] | Argentina | FICB = 62 vs IV NSAIDs (Diclofenac or Ketorolac) = 92 | 0.3 mL/kg 0.25% bupivacaine | VAS | FICB can provide equally effective analgesia as NSAIDs for up to 8 h |
Ma et al. 2018 [29] | China | CFICB = 44 vs oral drugs (tramadol and paracetamol) = 44 | 50 mL 0.4% ropivacaine, 5 mL/h 0.2% ropivacaine continuously | VAS (rest/movement), patients' satisfaction, side effects, length of hospital stay | Patients treated with CFICB received better analgesia both at rest and at movement compared to traditional analgesia |
Newman et al. 2013 [30] | UK | FICB = 56 vs FNB = 51 | 20–30 mL 0.5% levobupivacaine, weight-dependent | VAS, opioid consumption | Patients treated with FNB had better pain control and less morphine requirement |
Zhou et al. 2019 [31] | China | FICB = 77 vs FONB = 77 | 35 mL 0.4% ropivacaine | VAS (rest/exercise), requirement for analgesic drugs, postoperative complications | Both FONB and FICB were effective in acute pain control. FONB performed better in reducing pain and function recovery |
Cooper et al. 2019 [32] | Australia | FICB = 52 vs FNB = 48 | 20 mL 0.5% levobupivacaine | NRS | FICB can provide equivalent analgesia effect as FNB for femur fracture patients |
Reavley et al. 2015 [33] | UK | FICB = 88 vs “3-in-1”block = 90 | 2 mg/kg 0.5% bupivacaine | VAS | FICB was as effective as “3-in-1” block for immediate pain relief |
Aprato et al. 2018 [34] | Italy | FICB = 70 vs IAHI = 50 | 40 mL 0.25% ropivacaine | NRS (rest/movement), additional analgesic drug, adverse events | IAHI provided better pain management and reduced systemic analgesia consumption compared with FICB |
Wennberg et al. 2019 [35] | Sweden | FICB = 65 vs control = 60 | 30 mL 2 mg/mL ropivacaine | Changes of cognitive status | FICB did not affect cognitive status in this study |
| |||||
Application before surgical anesthesia | |||||
Yun et al. 2009 [36] | Korea | FICB = 20 vs IV alfentanil = 20 | 30 mL 0.375% ropivacaine | Time to achieve SA, VAS, quality of patient positioning, patient acceptance | FICB was more efficacious than IV alfentanil with better pain control during positioning and shorter time to achieve SA as well |
Diakomi et al. 2014 [37] | Greece | FICB = 21 vs IV fentanyl = 20 | 40 mL 0.5% ropivacaine | Time needed and quality of position, NRS, postoperative analgesia, morphine consumption, patient satisfaction | Patients who received FICB showed significantly lower pain score, shorter spinal performance time, and better quality of position |
Madabushi et al. 2016 [38] | India | FICB = 30 vs IV fentanyl = 30 | 30 mL 0.375% ropivacaine | VAS, sitting angle, positioning quality, time to perform SA, postoperative analgesic requirement | Patients who received FICB needed less time for SA and had better quality of positioning accompanied by superior analgesia |
Kacha et al. 2018 [39] | India | FICB = 50 vs placebo (normal saline) = 50 | 30 mL 0.25% ropivacaine | VAS, time of positioning SA, total duration of analgesia | FICB effectively provided analgesia during positioning for SA and significantly extended the total duration of analgesia |
| |||||
Postoperative use | |||||
Temelkovska-Stevanovska et al. 2014 [40] | Macedonia | FICB = 30 vs FNB = 30 | 40 mL 0.25% bupivacaine | VDS (rest/movement), additional analgesia, and duration for the first time, side effects | FNB provided superior postoperative pain relief versus FICB, and lower amount of supplemental analgesia |
Deniz et al. 2014 [41] | Turkey | FICB = 20 vs “3-in-1” block = 20 vs control = 20 | 30 mL 0.25% bupivacaine | VAS, opioid consumption, adverse effects, and cortisol and ACTH levels | Both FICB and “3-in-1” block can bring superior analgesia and reduction in opioid consumption. The two blocks also showed a suppression of stress hormones |
Bang et al. 2016 [42] | Korea | FICB = 11 vs. Non-FICB = 11 | 40 mL 0.2% ropivacaine | Postoperative VAS scores, opioid consumption, and adverse events | The FICB had a significant opioid-sparing effect in the first 24 hours after hemiarthroplasty |
Mostafa et al. 2018 [43] | Egypt | FICA = 30 vs. IV fentanyl = 30 | 35 mL 0.125% levobupivacaine + PC-FICA∗ | Postoperative VAS scores, additional analgesia requirement, and total additional analgesia assumption | PC-FICA provided a better quality of analgesia and decreased postoperative rescue analgesic requirement without increased side effects compared to PCA IV fentanyl |
Yamamoto et al. 2019 [44] | Japan | FICB = 25 vs IV acetaminophen = 28 | 40 mL 0.25% levobupivacaine | VAS (rest/movement), total number of rescue analgesics required, incidence of delirium | Patients treated with FICB received better pain control compared to IV NSAIDs without increasing the complication rate |
Thompson et al. 2020 [45] | America | FICB = 23 vs control = 24 | 30 mL 0.25% ropivacaine | Pain medication consumption, functional recovery, patient satisfaction | FICB significantly decreased postoperative consumption of morphine for breakthrough pain while increasing patient satisfaction |
Schulte et al. 2020 [46] | USA | FICB = 57 vs control = 40 | 45 to 60 mL 0.375% ropivacaine | VAS, MME, postoperative ambulatory distance | A single perioperative FIB for patients with hip fractures undergoing surgery may decrease opioid consumption and increase the likelihood that a patient is discharged home |
Diakomi et al. 2020 [47] | Greece | FICB = 91 vs sham FICB = 91 | 40 mL 0.5% ropivacaine | Incidence, intensity, and severity of CPSP at 3 and 6 months after hip fracture surgery | FICB in the perioperative setting may reduce the incidence, intensity, and severity of CPSP at 3 and 6 months after hip fracture surgery, providing safe and effective postoperative analgesia |
| |||||
Other benefits of FICB | |||||
Mouzopoulos et al. 2009 [48] | Greece | FICB = 102 vs placebo (water for injection) = 105 | 0.25 mg dose of 0.3 mL/kg bupivacaine | Perioperative delirium, mean duration of delirium | Severity and incidence of delirium were significantly lower in intermediate-risk patients treated with FICB, along with shorter mean duration of delirium |
Nie et al. 2015 [49] | China | CFICB = 51 vs PCIA (IV fentanyl) = 53 | 20–30 mL 0.5% ropivacaine, 0.1 mL/kg/h 0.25% ropivacaine continuously | Postoperative pain and complications (delirium, nausea and vomiting, and pruritus) | FICB showed a stronger effect on reducing postoperative nausea and vomiting, and pruritus, but with a higher incidence of developing delirium |
Hao et al. 2019 [50] | China | CFICB = 44 vs placebo (normal saline) = 46 | 30 mL 0.45% ropivacaine, 6 mL/h 0.25% ropivacaine continuously | Postoperative delirium, change in preoperative and postoperative pain scores, opioid consumption | The incidence of post-op delirium was lower for patients who received CFICB |
RCTs: randomized controlled trials; FICB: fascia iliaca compartment block; VRS: verbal rating scale; IM: intramuscular; IV: intravenous; NRS: numerical rating scale; VAS: visual analogue scale; NSAIDs: non-steroidal anti-inflammatory drugs; CFICB: continuous fascia iliaca compartment block; FNB: femoral nerve block; FONB: femoral obturator nerve block; IAHI: intra-articular hip injection; SA: spinal anesthesia; VDS: verbal descriptive scale; ACTH: adrenocorticotropic hormone; PCIA: patient-controlled intravenous analgesia; FICA: fascia iliaca compartment analgesia; PC-FICA:: patient-controlled fascia iliaca compartment analgesia; MME: morphine milligram equivalents; CPSP: chronic postsurgical pain. ∗Protocol: a continuous basal infusion of 4 mL/h levobupivacaine 0.125% and demand boluses of 2 ml with a lockout interval of 15 min.